HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of severe retro-peritoneal bleeding with recombinant factor VIIa in women with placenta percreta invading into the left broad ligament: unusual repeated ante-partum intra-abdominal bleeding.

Abstract
We experienced unusual repeated ante-partum intra-abdominal bleedings in a woman with placenta percreta invading into the left broad ligament, in whom recombinant factor VIIa was effective for controlling severe retro-peritoneal bleeding. A 34-year-old multiparaous woman with two prior cesarean sections presented acute abdominal pain at 16 weeks of gestation. She also represented with abdominal pain at 22 weeks of gestation, and a diagnostic laparoscopy revealed hemoperitoneum, although we could not identify the exact source of bleeding. She also represented with abdominal pain without vaginal bleeding at 27 weeks of gestation, and an MRI revealed a hematoma in the lower abdomino-pelvic region and placenta percreta invading into the left broad ligament. A classical cesarean section followed by hysterectomy with partial cystectomy was performed at 32 weeks of gestation. Since the bleeding from the retro-peritoneum could not be controlled by the use of fresh frozen plasma, recombinant factor VIIa was administered, resulting in successful hemostasis.
AuthorsMuhieddine Seoud, Samer Cheaib, Ghina Birjawi, Ayman Tawil, Faek Jamali
JournalThe journal of obstetrics and gynaecology research (J Obstet Gynaecol Res) Vol. 36 Issue 1 Pg. 183-6 (Feb 2010) ISSN: 1447-0756 [Electronic] Australia
PMID20178548 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Coagulants
  • Recombinant Proteins
  • recombinant FVIIa
  • Factor VIIa
Topics
  • Adult
  • Broad Ligament
  • Coagulants (therapeutic use)
  • Factor VIIa (therapeutic use)
  • Female
  • Hematoma (drug therapy, etiology)
  • Hemoperitoneum (drug therapy, etiology)
  • Humans
  • Myometrium (pathology)
  • Placenta Accreta (pathology)
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (drug therapy, etiology)
  • Pregnancy Trimester, Second
  • Recombinant Proteins (therapeutic use)
  • Retroperitoneal Space
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: